CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination with Abiraterone plus Prednisone in Men with High-Risk Metastatic Hormone- Sensitive Prostate Cancer

This Study is
No Longer Enrolling

Details
Age

Adult

Type of Study

Treatment

Locations

Memorial Hospital Central
Memorial Hospital North

Study ID

Protocol Number: 22-0782

More information available at ClinicalTrials.gov: NCT05288166

Categories

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers